-transparent.png){kind=logo}
Various sero-epidemiologic studies, including the preliminary report from Ibadan, have established that most women with premalignant and malignant carcinoma of the cervix have serologic evidence of infection of herpes type-2 virus. Using immunofluorescence method, the earlier report in Ibadan was confirmed, whereby the prevalence of HT-2 virus antibodies was shown to be significantly associated with carcinoma of the cervix, especially the squamous cell type. However, there was no such association with the grade and stage of the disease.
Related Publications
B Adelusi, and
B O Osunkoya, and
A Fabiyi
January 1978,
Journal of hygiene, epidemiology, microbiology, and immunology,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
December 1993,
Indian journal of cancer,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
January 1978,
Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
September 1974,
Revue canadienne de biologie,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
July 1973,
Ceskoslovenska gynekologie,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
May 1982,
American journal of epidemiology,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
August 1978,
Nederlands tijdschrift voor geneeskunde,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
August 2000,
East African medical journal,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
May 1975,
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
B Adelusi, and
B O Osunkoya, and
A Fabiyi
February 2002,
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
